Kelun Biotech Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Public

  • Employees
  • 1,542

Employees

  • Stock Symbol
  • 06990

Stock Symbol

  • Share Price
  • $21.66
  • (As of Friday Closing)

Kelun Biotech General Information

Description

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is an innovative biopharmaceutical company committed to the R&D, manufacturing and commercialization of novel drugs to address medical needs in China and globally. It is one of the first movers in the development of antibody-drug conjugates (ADCs), with over a decade of accumulated experience in ADC development. The company takes a systematic, indication-oriented approach to target the world's prevalent or hard-to-treat cancers, and other diseases and conditions affecting a large and underserved population.

Contact Information

Website
www.kelun-biotech.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • No. 666, Section 2, Xinhua Avenue
  • Wenjiang District
  • Chengdu, Sichuan
  • China
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
HKG
Vertical(s)
Manufacturing, Life Sciences, Oncology
Corporate Office
  • No. 666, Section 2, Xinhua Avenue
  • Wenjiang District
  • Chengdu, Sichuan
  • China

Kelun Biotech Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kelun Biotech Stock Performance

As of 24-Jan-2025, Kelun Biotech’s stock price is $21.66. Its current market cap is $4.92B with 227M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$21.66 $20.93 $8.14 - $28.82 $4.92B 227M 295K -$0.26

Kelun Biotech Financials Summary

As of 30-Jun-2024, Kelun Biotech has a trailing 12-month revenue of $261M.

In Thousands,
USD 		TTM 30-Jun-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 4,383,121 2,677,330
Revenue 260,833 217,741 119,375 5,006
EBITDA (16,619) (49,965) (52,357) (116,941)
Net Income (32,346) (81,151) (91,483) (137,801)
Total Assets 527,591 495,127 143,949 127,541
Total Debt 5,261 8,453 436,906 375,093
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Kelun Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kelun Biotech‘s full profile, request access.

Request a free trial

Kelun Biotech Patents

  • 262

    Total Documents Applications and Grants

  • Total Patents Families

  • 112

    Granted

  • 112

    Pending

  • Expiring in next 12 mo

Kelun Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250000994-A1 Combination therapies for the treatment of non-small cell lung cancer Pending 30-Jun-2023
US-20250000990-A1 Combination therapies for the treatment of cancer Pending 30-Jun-2023
AU-2023260131-A1 Antibody-drug conjugate, pharmaceutical composition thereof and use thereof Pending 29-Apr-2022
AU-2023259355-A1 Antibody-drug conjugates and preparation methods and use thereof Pending 29-Apr-2022
EP-4495118-A1 Use and treatment method of azetidine derivative Pending 18-Mar-2022
To view Kelun Biotech’s complete patent history, request access »

Kelun Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kelun Biotech ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Kelun Biotech’s complete esg history, request access »

Kelun Biotech FAQs

  • When was Kelun Biotech founded?

    Kelun Biotech was founded in 2016.

  • Where is Kelun Biotech headquartered?

    Kelun Biotech is headquartered in Chengdu, China.

  • What is the size of Kelun Biotech?

    Kelun Biotech has 1,542 total employees.

  • What industry is Kelun Biotech in?

    Kelun Biotech’s primary industry is Drug Discovery.

  • Is Kelun Biotech a private or public company?

    Kelun Biotech is a Public company.

  • What is Kelun Biotech’s stock symbol?

    The ticker symbol for Kelun Biotech is 06990.

  • What is the current stock price of Kelun Biotech?

    As of 24-Jan-2025 the stock price of Kelun Biotech is $21.66.

  • What is the current market cap of Kelun Biotech?

    The current market capitalization of Kelun Biotech is $4.92B.

  • What is Kelun Biotech’s current revenue?

    The trailing twelve month revenue for Kelun Biotech is $261M.

  • What is Kelun Biotech’s annual earnings per share (EPS)?

    Kelun Biotech’s EPS for 12 months was -$0.26.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »